We are live on ! Find out more
PCM

Palisade Capital Management Portfolio holdings

AUM $3B
1-Year Est. Return 14%
This Fund
S&P 500
This Quarter Est. Return
-5.74%
1 Year Est. Return
+14%
3 Year Est. Return
+46.63%
5 Year Est. Return
+57.43%
10 Year Est. Return
+264.35%
AUM
$4.35B
AUM Growth
-$586M
Cap. Flow
-$907M
Cap. Flow %
-20.85%
Top 10 Hldgs %
13.74%
Holding
450
New
24
Increased
64
Reduced
120
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Healthcare 13.76%
3 Financials 12.69%
4 Industrials 10.3%
5 Consumer Discretionary 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAN
76
DELISTED
The Aaron's Company Inc
AAN
$19.1M 0.44%
953,486
-56,639
-6% -$1.24M
POLY
77
DELISTED
Plantronics, Inc.
POLY
$19.1M 0.44%
484,292
-40,976
-8% -$1.17M
HCSG icon
78
Healthcare Services Group
HCSG
$1.53B
$19.1M 0.44%
1,026,422
-40,125
-4% -$692K
FTV icon
79
Fortive
FTV
$18.6B
$18.5M 0.42%
402,029
+10,625
+3% +$525K
CSTL icon
80
Castle Biosciences
CSTL
$979M
$18.4M 0.42%
409,232
+56,791
+16% +$2.35M
AVGOP
81
DELISTED
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
$18.3M 0.42%
9,328
-535
-5% -$987K
AMAT icon
82
Applied Materials
AMAT
$428B
$18.1M 0.42%
137,661
+1,282
+0.9% +$176K
HNGR
83
DELISTED
Hanger Inc.
HNGR
$18M 0.41%
980,295
-34,737
-3% -$634K
HMN icon
84
Horace Mann Educators
HMN
$2.11B
$17.9M 0.41%
428,197
-23,594
-5% -$946K
AHCO icon
85
AdaptHealth
AHCO
$759M
$17.9M 0.41%
1,115,180
+257,908
+30% +$4.64M
CDMO
86
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$17.5M 0.4%
858,426
-89,897
-9% -$1.83M
ABBV icon
87
AbbVie
ABBV
$435B
$17.4M 0.4%
107,566
-2,597
-2% -$377K
PRG icon
88
PROG Holdings
PRG
$1.71B
$17.2M 0.4%
598,710
-29,197
-5% -$1.03M
TRUP icon
89
Trupanion
TRUP
$1.18B
$16.9M 0.39%
189,114
-11,199
-6% -$1.03M
MATW icon
90
Matthews International
MATW
$739M
$16.8M 0.39%
520,133
+10,834
+2% +$371K
HRTX icon
91
Heron Therapeutics
HRTX
$92.9M
$16.7M 0.38%
2,921,107
-113,065
-4% -$827K
JNJ icon
92
Johnson & Johnson
JNJ
$625B
$16.5M 0.38%
93,141
+250
+0.3% +$42.5K
DHR.PRB
93
DELISTED
Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B
DHR.PRB
$16.1M 0.37%
10,224
+6,444
+170% +$9.83M
AMSF icon
94
AMERISAFE
AMSF
$540M
$16.1M 0.37%
324,173
-7,422
-2% -$379K
WFC.PRL icon
95
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$16M 0.37%
12,234
-1,203
-9% -$1.66M
AVGO icon
96
Broadcom
AVGO
$2.04T
$15.9M 0.37%
253,150
+53,800
+27% +$3.2M
ROCK icon
97
Gibraltar Industries
ROCK
$1.49B
$15.4M 0.35%
359,280
-19,124
-5% -$1.01M
AMZN icon
98
Amazon
AMZN
$2.96T
$15M 0.34%
91,820
-107,200
-54% -$16.6M
MD icon
99
Pediatrix Medical
MD
$2.2B
$14.4M 0.33%
612,749
-36,176
-6% -$886K
UNP icon
100
Union Pacific
UNP
$174B
$14.1M 0.32%
51,499
-60
-0.1% -$15.2K

Similar funds

Palisade Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Palisade Capital Management held 450 positions worth $4.35B, down 12% from $4.94B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Palisade Capital Management withdrew a net $907M in Q1 2022, closing 29 positions and reducing 120 holdings. Its most notable exit was MERITOR, Inc., an estimated $22.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Palisade Capital Management opened a new position in Advanced Micro Devices worth $12M.

  • Palisade Capital Management's largest Q1 2022 buy was Advanced Micro Devices: 109,902 shares worth $12M.
  • Palisade Capital Management added most to IAA, Inc. Common Stock in Q1 2022, an estimated $15.1M increase.
  • Palisade Capital Management's biggest Q1 2022 reduction was PDC Energy, Inc., cutting an estimated $17M.
  • Palisade Capital Management fully exited MERITOR, Inc. in Q1 2022, selling an estimated $22.2M.
  • Palisade Capital Management's ten largest holdings make up 14% of its $4.35B portfolio in Q1 2022.
  • Palisade Capital Management opened 24 new positions and closed 29 in Q1 2022.
  • Palisade Capital Management's portfolio value fell 12% quarter-over-quarter to $4.35B.

Based on Palisade Capital Management's 13F filing for Q1 2022, filed 9 May 2022.